Results 121 to 130 of about 28,261 (176)

Vaccine preparedness for Bundibugyo virus and lessons learned. [PDF]

NPJ Vaccines
Pletschette M, Biedenkopf N.
europepmc   +1 more source

Detection of Marburg Virus Antibodies 25 Years After Outbreak in Watsa, Democratic Republic of the Congo. [PDF]

J Infect Dis
Merritt S, Mukadi PK, Kompany JP, Halbrook M, Musene K, Martin SA, Beya M, Tambu M, Wong TAS, Muyembe-Tamfum JJ, Kaba DK, Lehrer AT, Kindrachuk J, Hoff NA, Mbala-Kingebeni P, Rimoin AW.   +15 more
europepmc   +1 more source

Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses. [PDF]

Nat Commun
Weidle C, Brunette N, Wrenn SP, Fiala B, Ravichandran R, Carr KD, Zak SE, Zumbrun EE, Bakken RR, Murphy M, Peng Z, Chan S, Skotheim R, Carter L, Correnti CE, Dye JM, Baker D, King NP, Borst AJ, Stewart LJ.   +19 more
europepmc   +1 more source

A Lethal Pseudofilovirus Model in <i>Ifnar1</i>(-/-) Mice Using Recombinant Vesicular Stomatitis Viruses. [PDF]

Viruses
Mamatkulova AV, Shuliakova IV, Zubkova OV, Reshetnikov DA, Iliukhina AA, Zorkov ID, Grousova DM, Savina DM, Popova O, Zrelkin DI, Goldovskaya PP, Samokhvalova EG, Azizyan VV, Shcheblyakov DV, Naroditsky BS, Gintsburg AL, Logunov DY.   +16 more
europepmc   +1 more source

Underinvestment in diagnostic and vaccine research & development has put the world at greater risk from the Bundibugyo virus epidemic in 2026. [PDF]

Virulence
Ly H.
europepmc   +1 more source

Molecular Phenotypes of Sex- and Age-Specific Differences Relating to Outcome in Patients With Ebola Virus Disease. [PDF]

J Infect Dis
Dong X, Rickett NY, Maes P, Orr R, MacGill T, Myers T, Fletcher T, Carroll MW, Hiscox JA.   +8 more
europepmc   +1 more source

Discovering host-viral protein interactions in autophagy: A LIR discovery pipeline for identifying LC3-interacting region motifs in highly virulent viruses. [PDF]

PLoS Pathog
Petraccione KD, Wahba HM, Ali MGH, Stocker T, Akhrymuk I, Swese Y, Sastre D, Silberfarb A, O'Maille PE, Omichinski JG, Kehn-Hall K.   +10 more
europepmc   +1 more source

Infektionsmodell des Ebola Virus Glykoprotein-exprimierenden rekombinanten Vesikulären Stomatitis-Virus (rVSV-EBOV-GP) in humanen zerebralen Organoiden: Generierung eines BSL-2 in vitro Systems zur Investigation der EBOV Persistenz im Gehirn

Das Ebola Virus (EBOV) ist ein negativ-strängiges RNA Virus und verursacht die Ebola- Viruskrankheit (EDV), eine schwere und akute systemische Erkrankung mit hoher Sterblichkeitsrate.
Sarwar, Amena
core  

Bundibugyo virus disease evidence map: a rapid research needs appraisal. [PDF]

EClinicalMedicine
Sigfrid L, Spasenoska D, O'Dwyer S, de Swart M, Harriss E, Mendy T, Villanueva G, Henschke N, Norton A.   +8 more
europepmc   +1 more source

Bundibugyo Virus Disease: Diagnostics and Medical Countermeasures for a Neglected Ebolavirus. [PDF]

Viruses
Kopp K.
europepmc   +1 more source